Ang panganib ng kamatayan sa mga pasyente na may pempigus
vulgaris has been substantially reduced by treat-
ment na may systemic corticosteroids.5 Kasalukuyang therapy ay binubuo ng mataas na dosis ng corticosteroids plus immunosuppressive agents.6 Ang kumbinasyon na ito madalas na nagiging sanhi ng pang-matagalang immunosuppression, the consequences of which are now the most
common cause of death in patients with pemphigus vulgaris.7 Patients who do not have a response to corticosteroids plus immunosuppressive agents
or who have severe side effects from this therapy have been successfully treated with intravenous immune globulin,8,9 na maaaring magamit bilang monotherapy at maaaring gumawa ng mga pang-matagalang remissions.
basahin ang natitirang bahagi ng artikulong ito sa: http://www.nejm.org/doi/pdf/10.1056/NEJMoa062930
